source
- China clamps down on investigator-initiated clinical trials, tightening oversightChina has announced tighter oversight of investigator-initiated trials (ITTs), requiring these studies to obtain approval from the National Medical Products Administration before they can begin. Th…
- AGC Biologics targets in-vivo gene therapies with stable producer lines and next-gen purificationThe industry is moving from ex vivo to in vivo gene delivery, a change that forces viral vector manufacturers to rethink scale, purity, cell lines and analytical methods. In in vivo approaches the…